ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Brain Cancer
Glioma
Cancer
Recurrence
Astrocytoma
Gliosarcoma

Glioblastoma (GBM) trials near Salt Lake City, UT, USA:

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-9012

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

Salt Lake City, Utah, United States and 20 other locations

Locations recently updated

The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma...

Enrolling
Glioblastoma (GBM)
Newly Diagnosed Glioblastoma
Drug: temozolomide (TMZ)
Drug: silevertinib in combination with temozolomide

Phase 2

Black Diamond Therapeutics

Salt Lake City, Utah, United States and 23 other locations

This study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma...

Active, not recruiting
Newly Diagnosed and Recurrent Glioblastoma
Other: Temozolomide
Drug: [68Ga]Ga-NeoB

Phase 1

Novartis
Novartis

Salt Lake City, Utah, United States and 15 other locations

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II...

Enrolling
Glioblastoma
Drug: Regorafenib
Drug: Temozolomide

Phase 2, Phase 3

Global Coalition for Adaptive Research

Salt Lake City, Utah, United States and 62 other locations

Optune® together with maintenance TMZ and placebo in newly diagnosed Glioblastoma (GBM) patients. The primary objective of the stud...

Enrolling
Glioblastoma
Drug: Temozolomide
Drug: Placebo

Phase 3

NovoCure
NovoCure

Salt Lake City, Utah, United States and 100 other locations

and tolerability of these combinations in adult participants with glioblastoma (GBM). Arm B which was previously added to the proto...

Enrolling
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Astrocytoma, Grade III
Drug: Debio 0123
Drug: Temozolomide

Phase 1, Phase 2

Debiopharm
Debiopharm

Salt Lake City, Utah, United States and 15 other locations

This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM).The following intervent...

Active, not recruiting
Glioblastoma
Procedure: Surgery
Drug: Abemaciclib

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Salt Lake City, Utah, United States and 6 other locations

This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM).The drugs involved in ...

Enrolling
Glioblastoma
Drug: Neratinib
Drug: CC-115

Phase 2

Patrick Wen, MD

Salt Lake City, Utah, United States and 11 other locations

Locations recently updated

are also impermeable to the passage of therapeutic molecules from the blood to the brain. The development of effective treatments against glioblastoma...

Enrolling
Glioblastoma
Recurrent Glioblastoma
Device: SonoCloud-9 (SC9)
Drug: Temozolomide

Phase 3

Carthera

Salt Lake City, Utah, United States and 50 other locations

The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma...

Enrolling
Glioblastoma
Glioblastoma Multiforme
Drug: Temozolomide
Drug: Eflornithine (Dose Level 2)

Phase 1

Orbus Therapeutics

Salt Lake City, Utah, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems